Phenominer Database Results (89 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 15 0.0 mg/dl 0.0 0.0 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67623 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 15 0.03 mg/dl 0.0 0.02 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67628 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.02 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67629 85
F344/NSlc serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 7 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67475 311
PD/Cub serum insulin level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 310 days 6 0.12 mg/dl 0.0 0.01 radioimmunoassay retroorbital plexus 0.0 0 70278 1318
GK/Jcl serum insulin level control condition Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103937 2884
GK/Jcl serum insulin level controlled hesperidin content diet (1 %) (for 28 days) Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103938 2884
Crl:WI serum insulin level control condition Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. blood insulin amount male 112 days 10 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 102942 2783
SS.ZUC-Leprfa-/-/Slc serum insulin level vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood insulin amount male 91 days 6 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 101959 2644
WKY/NMolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106926 3071
WKY/NMolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106927 3071
GK/MolTac serum insulin level anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. blood insulin amount female 98 days 10 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 110280 3168
HanTac:WH serum insulin level control IgG monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. blood insulin amount female 98 days 8 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 110277 3168
HanTac:WH serum insulin level anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. blood insulin amount female 98 days 8 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 110278 3168
GK/MolTac serum insulin level control IgG monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. blood insulin amount female 98 days 9 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 110279 3168
GK/Jcl serum insulin level fasting Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 154 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 110215 3167
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.01 mg/dl 0.0 0.0 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67624 85
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.07 mg/dl 0.02 0.06 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67640 85
F344/NSlc serum insulin level fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. blood insulin amount male 210 days 9 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0 gastric gavage 0 min 66176 716
BB/OK serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 20 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 67939 227
WBN/KobSlc serum insulin level controlled protein content diet (for 120 days) then fasting (for 9 hours) Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. blood insulin amount male 120 days 5 0.0 mg/dl 0.0 0.0 oral glucose tolerance test glucose challenge 0 min serum glucose 12900 321
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 15 0.07 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67625 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.01 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67631 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 185 days 10 0.03 mg/dl 0.0 0.01 enzyme linked immunosorbent assay tail vein 0.0 0 67645 85
DA/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood insulin amount female 196 days-224 days 12 serial mean 0.0 mg/dl radioimmunoassay ophthalmic venous plexus 0.0 0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67920 251
BB.SHR-(Gnal-D18Mit9)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 25 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 70100 324
GK/Jcl serum insulin level controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days) Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103939 2884
SD-Lepem1Sage-/- serum insulin level fasting (for 16 hours) Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. blood insulin amount not specified 28 days 10 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 104536 2969
Crlj:WI serum insulin level fasting (for 16 hours) Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481. blood insulin amount male 56 days 5 0.0 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 110770 3185
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106918 3071
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106919 3071
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106921 3071
GK/MolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 240 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106924 3071
Jcl:WI serum insulin level fasting Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 154 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 110213 3167
Jcl:WI serum insulin level vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 140 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 glucose 30 min 110220 3167
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.07 mg/dl 0.01 0.03 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67627 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 20 0.01 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67657 85
GK/MolTac serum insulin level control condition Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. blood insulin amount male 112 days 8 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 102943 2783
SS.ZUC-Leprfa+/+/Slc serum insulin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood insulin amount male 126 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 101915 2642
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.03 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67626 85
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.07 mg/dl 0.02 0.06 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67636 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 185 days 9 0.02 mg/dl 0.0 0.01 enzyme linked immunosorbent assay tail vein 0.0 0 67644 85
BN/Cub serum insulin level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 300 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70275 1318
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 307 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70277 1318
SS.ZUC-Leprfa-/-/Slc serum insulin level fasting (for 16 hours) Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. blood insulin amount male 126 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 101916 2642
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106920 3071
GK/MolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106923 3071
BB.SHR-(D4Got41-Tacr1)/K serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 20 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 11938 227
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.05 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67635 85
WOKW serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood insulin amount female 196 days-224 days 12 serial mean 0.0 mg/dl radioimmunoassay ophthalmic venous plexus 0.0 0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67919 251
F344.OLETF-(D8Rat58-D8Mgh17)/Tj serum insulin level fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. blood insulin amount male 210 days 20 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0 gastric gavage 0 min 66177 716
BN/CrlCrlj serum insulin level controlled protein content diet (for 120 days) then fasting (for 9 hours) Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. blood insulin amount male 120 days 5 0.0 mg/dl 0.0 0.0 oral glucose tolerance test glucose challenge 0 min serum glucose 12911 321
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 15 0.08 mg/dl 0.01 0.05 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67634 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 15 0.07 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67637 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 20 0.01 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67658 85
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67477 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67478 311
PD/Cub serum insulin level fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 300 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70274 1318
PD/Cub serum insulin level controlled sucrose content diet (for 7 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 307 days 6 0.01 mg/dl 0.0 0.0 radioimmunoassay retroorbital plexus 0.0 0 70276 1318
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 32 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 70099 324
WOKW/K serum insulin level control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. blood insulin amount not specified 196 days-224 days 12 0.0 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 96846 1123
Jcl:WI serum insulin level control condition Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. blood insulin amount male 52 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 103936 2884
GK/MolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 60 days 6 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106917 3071
GK/MolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 11 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106925 3071
Jcl:WI serum insulin level fasting then glucose solution (2 g/kg) (for 0.5 hours) Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 140 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 glucose 30 min 110217 3167
Jcl:WI serum insulin level vildagliptin (30 mg/kg/d) (for 92 days) then fasting then glucose solution (2 g/kg) (for 0.5 hours) Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 140 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 glucose 30 min 110218 3167
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.0 mg/dl 0.0 0.0 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67622 85
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.06 mg/dl 0.01 0.03 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67630 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.05 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67638 85
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 46 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 12981 324
BB.WOKW-(D4Got41-Fabp1)/K serum insulin level control condition Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. blood insulin amount male 224 days 16 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 ng/ml 11942 227
BN/CrlCrlj serum insulin level controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. blood insulin amount male 120 days 5 0.0 mg/dl 0.0 0.0 oral glucose tolerance test glucose challenge 30 min glucose dose not specified serum glucose 12912 321
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.01 mg/dl 0.0 0.02 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67633 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 20 0.0 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67656 85
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 7 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67476 311
BN/Cub serum insulin level controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. blood insulin amount male 310 days 6 0.08 mg/dl 0.02 0.04 radioimmunoassay retroorbital plexus 0.0 0 70279 1318
SS.ZUC-Leprfa-/-/Slc serum insulin level Atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood insulin amount male 91 days 7 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 101960 2644
SS.ZUC-Leprfa-/-/Slc serum insulin level Atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood insulin amount male 91 days 7 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 101961 2644
GK/CskCrlj serum insulin level fasting (for 16 hours) Ohta T, et al., Br J Pharmacol. 1999 Apr;126(7):1674-80. doi: 10.1038/sj.bjp.0702481. blood insulin amount male 56 days 5 0.01 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 110771 3185
WKY/NMolTac serum insulin level control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106922 3071
WKY/NMolTac serum insulin level fasting (for 6 hours) Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. blood insulin amount female 420 days 9 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 fasting insulin, non fasting insulin 106928 3071
Jcl:WI serum insulin level vildagliptin (30 mg/kg/d) (for 106 days) then fasting Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 154 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 110214 3167
GK serum insulin level vildagliptin (30 mg/kg/d) (for 106 days) then fasting Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 154 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 110216 3167
GK/Jcl serum insulin level fasting then glucose solution (2 g/kg) (for 0.5 hours) Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. blood insulin amount male 140 days 7 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay 0.0 glucose 30 min 110219 3167
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 15 0.01 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67632 85
F344.GK-(D1Mgh10-D1Rat119)/Swe serum insulin level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 185 days 10 0.04 mg/dl 0.0 0.01 enzyme linked immunosorbent assay tail vein 0.0 0 67646 85
WBN/KobSlc serum insulin level controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. blood insulin amount male 120 days 5 0.0 mg/dl 0.0 0.0 oral glucose tolerance test glucose challenge 30 min glucose dose not specified serum glucose 12904 321
DA/K serum insulin level control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. blood insulin amount not specified 196 days-224 days 12 0.0 mg/dl 0.0 0.0 radioimmunoassay 0.0 0 96847 1123
NTac:SD serum insulin level fasting (for 16 hours) Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. blood insulin amount not specified 28 days 10 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 104535 2969